Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
about
Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Fosmetpantotenate (RE-024), a ...... fficacy in nonclinical models.
@en
Fosmetpantotenate (RE-024), a ...... fficacy in nonclinical models.
@nl
type
label
Fosmetpantotenate (RE-024), a ...... fficacy in nonclinical models.
@en
Fosmetpantotenate (RE-024), a ...... fficacy in nonclinical models.
@nl
prefLabel
Fosmetpantotenate (RE-024), a ...... fficacy in nonclinical models.
@en
Fosmetpantotenate (RE-024), a ...... fficacy in nonclinical models.
@nl
P2093
P2860
P1433
P1476
Fosmetpantotenate (RE-024), a ...... efficacy in nonclinical models
@en
P2093
Andrew Vaino
Annalise Di Marco
Edith Monteagudo
Kathryn A Lyons
Maria G Beconi
Maria S Quinton
Steven Harper
P2860
P304
P356
10.1371/JOURNAL.PONE.0192028
P407
P577
2018-03-09T00:00:00Z